Collectively, our studies support that lipid-lowering actions are critical for glucose-lowering effects of leptin, and demonstrate that LEPRs in RIP-Cre25Mgn neurons mediate anti-dyslipidemia actions of leptin in an insulin-independent manner. The gene discussed is LEP; the disease is metabolic syndrome.